Home/Companies/Pharma/Kent Pharmaceuticals

Kent Pharmaceuticals

UK·Active·7yr hold

Entry

2019

Hold

7yr

Status

Active

Who owns Kent Pharmaceuticals?

Kent Pharmaceuticals is currently owned by Apera Asset Management through Apera Capital Private Debt Fund I (2019 vintage), since 2019. Across its history, Kent Pharmaceuticals has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-29

Most recent investor

Apera Asset Management

Apera Capital Private Debt Fund I · 2019 · Private Debt

2 ownership periods · full history below

Key facts

HQUK

SectorPharma

StatusActive

Ownership history

2 ownership periods · co-invest detected

Active

Co-held by Duke Street and Apera Asset Management since 2019.

Co-invest · 2 holders · 2019 · present

Duke StreetActive

2019 · present(7yr) · DS Cornerstone Fund · 2017 · Buyout

Apera Asset ManagementActive

2019 · present(7yr) · Apera Capital Private Debt Fund I · 2019 · Private Debt

More from Apera Capital Private Debt Fund I

Other portfolio companies in the same fund.

Business Services

Real Digital International

Business Services

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert

SHS Gesellschaft für Beteiligungsmanagement

SHS Gesellschaft für Beteiligungsmanagement

Netherlands· 2026

Claret Capital Partners

Switzerland· 2026

Track Kent Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Kent Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment

Save this company to your watchlist

Exit buyers and MOIC on realized deals (Pro)

or

Continue with email

Already a member? Sign in

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue